VC

Venkateswarlu Chintagumpala

Active Director Director DIN 09830232
DIN 09830232 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkateswarlu Chintagumpala

Data last updated:

Venkateswarlu Chintagumpala is a Director at Aarvintej Medical And Pharma India Private Limited (since 2022). The company operates in Healthcare.

DIN 09830232
Primary Designation Director
Industry Healthcare
First Appointment 20 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Dec 20222022Active

Board colleagues of Venkateswarlu Chintagumpala

Directorship timeline

Open interactive timeline →
Aarvintej Medical And Pharma India Private Limited
Premium access

Shareholding and investment profile for Venkateswarlu Chintagumpala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkateswarlu Chintagumpala

Venkateswarlu Chintagumpala currently holds 1 directorship: Aarvintej Medical And Pharma India Private Limited (Director, since 20 Dec 2022).

Venkateswarlu Chintagumpala was first appointed on 20 Dec 2022 as Director at Aarvintej Medical And Pharma India Private Limited.

The current boards of Venkateswarlu Chintagumpala's companies include Tejaswi Venigalla (Aarvintej Medical And Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available